Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia

Cancer Epidemiology

Volumn 36, Issue 6, 2012, Pages 560-565

  Ishihara, Kaori ^a,b   Sasaki, Daisuke ^a,b   Tsuruda, Kazuto ^a   Inokuchi, Naoko ^a   Nagai, Kazuhiro ^a,b   Hasegawa, Hiroo ^a,b   Yanagihara, Katsunori ^a,b   Kamihira, Shimeru ^a,b  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

ATL; Biomarker; Microarray; MiRNA; Plasma RNA

Indexed keywords

CD4 ANTIGEN; MICRORNA; MICRORNA 126; MICRORNA 130A; MICRORNA 155; MICRORNA LET 7B; MICRORNA LET 7G; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PLASMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA;

CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MICRORNAS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84868302878     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.07.002     Document Type: Article

References (22)

1. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77(December (12)):7415-7419.
2. Yoshida M., Seiki M., Yamaguchi K., Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984, 81(April (8)):2534-2537.
3. Takasaki Y., Iwanaga M., Imaizumi Y., Tawara M., Joh T., Kohno T., et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 2010, 115(June (22)):4337-4343. [Epub 2010 Mar 26].
4. Usui T., Yanagihara K., Tsukasaki K., Murata K., Hasegawa H., Yamada Y., et al. Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology 2008, 5(April):34.
5. Bellon M., Lepelletier Y., Hermine O., Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 2009, 113(May (20)):4914-4917. [Epub 2009 Feb 26].
6. Yeung M.L., Yasunaga J., Bennasser Y., Dusetti N., Harris D., Ahmad N., et al. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 2008, 68(November (21)):8976-8985.
7. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002, 99(November (24)):15524-15529. [Epub 2002 Nov 14].
8. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435(June (7043)):828-833.
9. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105(July (30)):10513-10518. [Epub 2008 Jul 28].
10. Tavazoie S.F., Alarcón C., Oskarsson T., Padua D., Wang Q., Bos P.D., et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451(January (7175)):147-152.
11. Sasaki D., Imaizumi Y., Hasegawa H., Osaka A., Tsukasaki K., Choi Y.L., et al. Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy. Haematologica 2011, 96(May (5)):712-719. [Epub 2011 Jan 12].
12. Davoren P.A., McNeill R.E., Lowery A.J., Kerin M.J., Miller N. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 2008, 9(August):76.
13. Jeang K.T. Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?. Oncotarget 2010, 1(October (6)):453-456.
14. Pichler K., Schneider G., Grassmann R. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology 2008, 5(November):100.
15. Tomita M., Tanaka Y., Mori N. MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells. Int J Cancer 2009, (December). [Epub ahead of print].
16. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005, 102(March (10)):3627-3632.
17. Guo C., Sah J.F., Beard L., Willson J.K., Markowitz S.D., Guda K. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008, 47(November (11)):939-946.
18. Donnem T., Lonvik K., Eklo K., Berg T., Sorbye S.W., Al-Shibli K., et al. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer 2011, (January). [Epub ahead of print].
19. Sun Y., Bai Y., Zhang F., Wang Y., Guo Y., Guo L. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun 2010, 391:1483-1489.
20. Feng R., Chen X., Yu Y., Su L., Yu B., Li J., et al. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010, 298(December (1)):50-63. [Epub 2010 Jul 8].
21. Fathers K.E., Rodrigues S., Zuo D., Murthy I.V., Hallett M., Cardiff R., et al. CrkII transgene induces atypical mammary gland development and tumorigenesis. Am J Pathol 2010, 176:446-460.
22. Kaira K., Oriuchi N., Imai H., Shimizu K., Yanagitani N., Sunaga N., et al. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci 2008, 99:2380-2386.